Danny Chan

Danny Chan is an experienced pharmaceutical sales professional currently serving as an Institutional Business Manager at Azurity Pharmaceuticals since September 2022. Prior roles include Regional Account Manager at AcelRx Pharmaceuticals, where tenure lasted from July 2019 to October 2022, and Sr. Executive Territory Business Manager at Arbor Pharmaceuticals from July 2016 to July 2019, earning notable accolades such as the 2018 Arbor Star Award and multiple top performer recognitions. Danny's extensive background includes positions at XenoPort, Inc. as Sr. Neuro Health Specialist, Amarin Corporation as Specialty Sales Professional, and Spectrum Pharmaceuticals as Senior Oncology Specialist, where significant contributions included reintroducing ZEVALIN to the oncology community. Earlier roles at CardioNet, GlaxoSmithKline, Reliant Pharmaceuticals, and inVentiv Health further solidified a strong foundation in cardiovascular and specialty sales, supported by a degree in Economics from the University of the East.